Barriers to scaling up hepatitis C treatment in Malaysia: a qualitative study with key stakeholders
Abstract Background While the availability of generic direct-acting antivirals (DAAs) opens the door for large-scale treatment, the care hubbell 5362w for people living with hepatitis C virus (HCV) in Malaysia is shifting toward a tripartite partnership between the public health system, correctional settings and civil society organizations (CSOs).T